🔎 Today’s Daily Sift: Longevity Longevity is becoming three different industries. Science is studying aging at the cellular level. Governments are confronting the cost of dependency. Luxury wellness is selling the feeling of biological control. New research highlighted by Science points to declining RNA editing as a possible driver of intestinal stem cell aging. When the enzyme ADAR loses activity, growth signaling becomes harder to regulate and healthy tissue renewal begins to break down. (Science) The signal is bigger than the gut. Aging may be less about cells simply wearing out and more about biological coordination slowly becoming unstable. At the same time, Britain is preparing another attempt to reform adult social care. Families can lose enormous sums paying for long term support, yet every proposed solution creates political resistance over taxes, insurance, and public spending. (Reuters) Then comes the consumer market. Longevity is now being packaged through ful...